Episode 4: Individualizing Treatment in Rheumatoid Arthritis: The Crucial Impact of Patient Heterogeneity
Biologic Therapy In Rheumatoid Arthritis
English - December 05, 2008 11:03 - 14 minutes - 18.1 MB - ★★★★ - 4 ratingsScience Health & Fitness Medicine rheumatoid arthritis rheumatology news international biologic therapy alpha tnf schering Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Professor VonVollenhoven discusses factors which distinguish individual responses by patients with rheumatoid arthritis to various anti-TNF agents. He describes observations of radiologic and clinical progression of illness in subgroups of patients and provides an overview of considerations in choosing one pharmacologic agent over another. Professor VonVollenhoven also discusses recent research on the role of biologic markers for RA.